BR0318192A - regimes contraceptivos transdérmicos prolongados - Google Patents
regimes contraceptivos transdérmicos prolongadosInfo
- Publication number
- BR0318192A BR0318192A BRPI0318192-8A BR0318192A BR0318192A BR 0318192 A BR0318192 A BR 0318192A BR 0318192 A BR0318192 A BR 0318192A BR 0318192 A BR0318192 A BR 0318192A
- Authority
- BR
- Brazil
- Prior art keywords
- progestogen
- therapy cycle
- days
- contraception
- administering
- Prior art date
Links
- 239000003433 contraceptive agent Substances 0.000 title abstract 3
- 230000002254 contraceptive effect Effects 0.000 title abstract 3
- 230000002035 prolonged effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000000583 progesterone congener Substances 0.000 abstract 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 239000000262 estrogen Substances 0.000 abstract 2
- 229940011871 estrogen Drugs 0.000 abstract 2
- 102000005262 Sulfatase Human genes 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 108060007951 sulfatase Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
"REGIMES CONTRACEPTIVOS TRANSDéRMICOS PROLONGADOS". A presente invenção refere-se a um método de contracepção compreendendo a etapa de administração, a uma mulher que menstrua, de um ciclo de terapia contraceptiva, o referido ciclo de terapia incluindo, durante pelo menos 42 dias consecutivos, a administração de uma combinação de um estrogênio e um progestogênio em uma dose diária contraceptivamente eficaz, em que o referido progestogênio é um progestogênio potente para inibição de sulfatase e o referido ciclo de terapia incluindo 4-8 dias os quais são isentos de administração de estrogênio, seguido pelos referidos pelo menos 42 dias sucessivos. Um método de contracepção também é descrito o qual proporciona controle intensificado de sangramento e taxas de continuação e satisfação intensificadas em mulheres que menstruam usando o método.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/385,597 US20030219471A1 (en) | 2002-03-11 | 2003-03-11 | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
| PCT/US2003/023134 WO2004080442A1 (en) | 2003-03-11 | 2003-07-24 | Extended transdermal contraceptive regimens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0318192A true BR0318192A (pt) | 2006-03-21 |
Family
ID=32987305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0318192-8A BR0318192A (pt) | 2003-03-11 | 2003-07-24 | regimes contraceptivos transdérmicos prolongados |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030219471A1 (pt) |
| EP (1) | EP1613293A1 (pt) |
| KR (1) | KR20070006543A (pt) |
| CN (1) | CN1771024A (pt) |
| AU (1) | AU2003252139A1 (pt) |
| BR (1) | BR0318192A (pt) |
| CA (1) | CA2517778A1 (pt) |
| CR (1) | CR8010A (pt) |
| EC (1) | ECSP056009A (pt) |
| MX (1) | MXPA05009656A (pt) |
| RU (1) | RU2005128284A (pt) |
| WO (1) | WO2004080442A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| NZ591627A (en) | 2001-12-05 | 2012-09-28 | Teva Womens Health Inc | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| US7772219B2 (en) | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| US7576226B2 (en) * | 2003-06-30 | 2009-08-18 | Richter Gedeon Vegyeszeti Gyar Rt. | Process of making isomers of norelgestromin and methods using the same |
| CA2771944A1 (en) | 2003-07-16 | 2005-01-27 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| TW200626161A (en) * | 2004-10-07 | 2006-08-01 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| MX2008011074A (es) * | 2006-03-02 | 2008-09-10 | Warner Chilcott Co Inc | Metodo anticonceptivo oral multifasico de ciclo prolongado. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545397A (en) * | 1969-03-17 | 1970-12-08 | Dowty Technical Dev Ltd | Air-cushion vehicles and like craft |
| IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
| US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
| US5188835A (en) * | 1986-06-16 | 1993-02-23 | Kabi Pharmacia Ab | Intravaginal devices |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
| US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
| US5006342A (en) * | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
| DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
| PL181582B1 (pl) * | 1995-06-07 | 2001-08-31 | Ortho Mcneil Pharm Inc | Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL |
| AU2003218119A1 (en) * | 2002-03-11 | 2003-09-29 | Janssen Pharmaceutica N.V. | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
-
2003
- 2003-03-11 US US10/385,597 patent/US20030219471A1/en not_active Abandoned
- 2003-07-24 AU AU2003252139A patent/AU2003252139A1/en not_active Abandoned
- 2003-07-24 KR KR1020057016954A patent/KR20070006543A/ko not_active Withdrawn
- 2003-07-24 EP EP03816278A patent/EP1613293A1/en not_active Withdrawn
- 2003-07-24 CN CNA038264390A patent/CN1771024A/zh active Pending
- 2003-07-24 WO PCT/US2003/023134 patent/WO2004080442A1/en not_active Ceased
- 2003-07-24 BR BRPI0318192-8A patent/BR0318192A/pt not_active IP Right Cessation
- 2003-07-24 RU RU2005128284/14A patent/RU2005128284A/ru not_active Application Discontinuation
- 2003-07-24 CA CA002517778A patent/CA2517778A1/en not_active Abandoned
- 2003-07-24 MX MXPA05009656A patent/MXPA05009656A/es unknown
-
2005
- 2005-09-08 EC EC2005006009A patent/ECSP056009A/es unknown
- 2005-09-28 CR CR8010A patent/CR8010A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070006543A (ko) | 2007-01-11 |
| CN1771024A (zh) | 2006-05-10 |
| RU2005128284A (ru) | 2006-02-10 |
| WO2004080442A1 (en) | 2004-09-23 |
| US20030219471A1 (en) | 2003-11-27 |
| MXPA05009656A (es) | 2006-03-08 |
| CR8010A (es) | 2009-01-16 |
| ECSP056009A (es) | 2006-07-28 |
| AU2003252139A1 (en) | 2004-09-30 |
| CA2517778A1 (en) | 2004-09-23 |
| EP1613293A1 (en) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO986104L (no) | Progesteron-anti-progesteron regimer | |
| ES2033850T5 (es) | Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas. | |
| CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| ATE175353T1 (de) | Verfahren und system zur empfängnisverhütung | |
| ATE239483T1 (de) | Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption | |
| KR960704553A (ko) | 적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen) | |
| NZ503890A (en) | Oral contraceptives comprising non-uterotrophic anti-estrogens and progestin | |
| PL323729A1 (en) | Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen | |
| BR8807426A (pt) | Composicoes e metodos contraceptivos e controle do cancer de mama | |
| AR048722A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| EE05259B1 (et) | Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks | |
| HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
| BRPI0516247A (pt) | métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente | |
| MXPA05009656A (es) | Regimenes contraceptivos transdermicos extendidos. | |
| ES2397983T3 (es) | Procedimiento anticonceptivo oral multifásico de ciclo prolongado | |
| NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen | |
| CY1112542T1 (el) | Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας | |
| BR0208968A (pt) | Inibição de aromatase para aumentar a reprodução assistida | |
| KR960030945A (ko) | 엘(l)-아르기닌을 주성분으로 한 남성 성기능장애 치료제 | |
| KR890014118A (ko) | 골다공증 치료 | |
| YU30103A (sh) | Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |